InvestorsHub Logo
Followers 61
Posts 7526
Boards Moderated 2
Alias Born 02/10/2010

Re: Its_lose_not_loose post# 102978

Wednesday, 10/29/2014 3:02:28 PM

Wednesday, October 29, 2014 3:02:28 PM

Post# of 146212
I wasn't asked specifically,... but I'll add my $0.02.

Simply stated, NNVC has developed an anti-viral treatment for ANY AND ALL viruses.



IMO this is a significant overstatement and does at least loosely imply that something is in place and ready to be used.

It is also an overstatement at some significant level that even if say - Flucide and/or Ebolacide works well and works well soon - that the development model used and the development platform used would work on "ANY AND ALL viruses"

That is one of my complaints with what Harris reports when he talks about NNVC - and is one of the reasons that over the years here that many have become disenchanted with the timeline that company has taken to get to this relatively advanced testing point.

The ADIF Technology
http://www.nanoviricides.com/adiftechnology.html

Has huge amounts of potential to be adapted to a broad array of viruses. Potential and reality are two quite different things most of the time.

However - for those viruses where a good 3-D model of a cell-binding ligand can be developed (like for example those on Flucide, or potentially on Ebolacide2) - the potential to develop effective antiviral treatments is very high.

So yes - this statement is (to be kind) premature and could easily be considered deceptive.

It is important to note (however) that the statement was not made by NNVC or its insiders - but rather by an interested outsider with a history of being an avid supporter of NNVC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News